Skip to main content
Log in

Pituitary down-regulation in IVF cycles: Is it necessary to use strict criteria?

  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Purpose

In a retrospective study we have reviewed the data of 570 consecutive IVF cycles in which a GnRH agonist (GnRHa) was started in the early follicular phase (long protocol). Cycles were divided in groups according to estradiol levels before HMG administration: A, <20 pg/ml; B, 20 to 50pg/ml; C, 51 to 100pg/ml. Our objective was to determine if the degree of pituitary suppression had any effect on the ovarian response to stimulation by exogenous gonadotropins, and/or on the IVF outcome.

Results

There were no significant differences in cycle cancellation rates, no. of days of stimulation and ampoules of HMG, serum estradiol after HMG, no. of oocytes retrieved and fertilization rates between groups. Pregnancy rates (19.4%, 21% and 31.8%/cycle, and 24.1%, 27.5% and 37.8%/embryo transfer, respectively) and live-birth rates.(16.2%, 16.1% and 25.0%/cycle, 20.1%, 21.2% and 29.7%/embryo transfer, respectively) were also not significantly different.

Conclusions

The degree of pituitary suppression had no effects on either the ovarian response to gonadotropins (including HMG requirements) or the overall IVF results.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Porter RN, Smith W, Craft IL, Abdulwahid NA, Jacobs HS: Induction of ovulation for in vitro fertilization using Buserelin and gonadotropins. Lancet 1984;2:1284–1285

    Google Scholar 

  2. Neveu S, Hedon B, Bringer J, Chinchole JM, Arnal F, Humeau C, Cristol P, Viala JL: Ovarian stimulation by a combination of gonadotropin-releasing hormone agonist and gonadotropins for in vitro fertilization. Fertil Steril 1987;47:639–643

    PubMed  Google Scholar 

  3. Fleming R, Coutts JRT: Induction of multiple follicular growth in normally menstruating women with endogenous gonadotropin suppression. Fertil Steril 1986;45:226–230

    PubMed  Google Scholar 

  4. Wildt L, Diedrich K, Vander Ven H, Al Hasami S, Hubner H, Klase R: Ovarian hyperstimulation for in-vitro fertilization controlled by GnRH agonist administrated in combination with human menopausal gonadotropins. Hum Reprod 1986;1:15–19

    PubMed  Google Scholar 

  5. Smitz J, Devroey P, Braeckmans P, Camus M, Khan I, Staessen C, VanWaesberghe LV, Wisanto A, Van Steirteghem AC: Management of failed cycles in an IVF/GIFT programme with the combination of a GnRh analogue and HMG. Hum Reprod 1987;2:309–314

    PubMed  Google Scholar 

  6. Serafini P, Stone B, Kerin J, Batzofin J, Quinn P, Marrs RP: An alternate approach to controlled ovarian hyperstimulation in “poor responders”: pretreatment with gonadotropin-releasing hormone analog. Fertil Steril 1988;49:90–95

    PubMed  Google Scholar 

  7. Garcia JE, Padilla SL, Bayati J, Baramki TA: Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: a better alternative for ovulation induction in in vitro fertilization. Fertil Steril 1990;53:302–305

    PubMed  Google Scholar 

  8. Hughes EG, Fedorkow DM, Daya S, Sagle MA, Koppel P, Collins JA: The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials. Fertil Steril 1992;58:888–896

    PubMed  Google Scholar 

  9. Dimitry ES, Bates SA, Oskarsson T, Margara R, Winston RML: Programming in vitro fertilization for a 5- or 3-day week. Fertil Steril 1991;55:934–938

    PubMed  Google Scholar 

  10. Horvath PM, Styler M, Hammond JM, Shelden RM, Kemmann E: Exogenous gonadotropin requirements are increased in leuprolide suppressed women undergoing ovarian stimulation. Fertil Steril 1988;49:159–162

    PubMed  Google Scholar 

  11. Antoine JM, Salat-Baroux J, Alvarez S, Cornet D, Tibi Ch, Mandelbaum J, Plachot M: Ovarian stimulation using human menopausal gonadotrophins with or without LHRH analogues in a long protocol for in vitro fertilization: a prospective randomized comparison. Hum Reprod 1990;5:565–569

    PubMed  Google Scholar 

  12. Feldberg D, Ashkenazi J, Dicker D, Yeshaya A, Goldman GA, Goldman JA: Ovarian cyst formation; a complication of gonadotropin-releasing hormone agonist therapy. Fertil Steril 1989;51:42–45

    PubMed  Google Scholar 

  13. Rizk B, Tan SL, Kingsland C, Steer C, Mason BA, Campbell S: Ovarian cyst aspiration and the outcome of in vitro fertilization. Fertil Steril 1990;54:661–664

    PubMed  Google Scholar 

  14. Hull MGR, Armatage RJ, McDermott A: Use of follicle-stimulating hormone alone (urofollitropin) to stimulate the ovaries for assisted conception after pituitary desensitization. Fertil Steril 1994;62:997–1003

    PubMed  Google Scholar 

  15. Golan A, Herman A, Soffer Y, Bukovsky I, Ron-El R: Ultrasonic control without hormone determination for ovulation induction in in-vitro fertilization/embryo transfer with gonadotrophin-releasing hormone analogue and human menopausal gonadotrophin. Hum Reprod 1994;9:1631–1633

    PubMed  Google Scholar 

  16. Craft I, Brindsen P: Alternatives for IVF: the outcome of 1,071 first GIFT procedures. Hum Reprod 1989;4(Suppl.):29–36

    Google Scholar 

  17. Pantos K, Meimeth-Damianaki T, Vaxevanoglou T, Kapetanakis E: Prospective study of a modified gonadotropin-releasing hormone agonist long protocol in an in vitro fertilization program. Fertil Steril 1994;61:709–713

    PubMed  Google Scholar 

  18. Cordeiro I, Calhaz-Jorge C, Leal F, Barata M, Pereira-Coelho A: Fractured zona oocytes in in-vitro fertilization cycles stimulated with gonadotrophin-releasing hormone analogue and human menopausal gonadotrophin. Hum Reprod 1993;8:609–611

    PubMed  Google Scholar 

  19. Tan SL, Maconochie N, Doyle P, Campbell S, Balen A, Bekir J, Brindsen P, Edwards RG, Jacobs HS: Cumulative conception and live-birth rates after in vitro fertilization with and without the use of long, short, and ultrashort regimens of the gonadotropin-releasing hormone agonist buserelin. Am J Obstet Gynecol 1994;171:513–520

    PubMed  Google Scholar 

  20. Penzias AS, Jones EE, Seifer DB, Grifo JA, Thatcher SS, DeCherney AH: Baseline ovarian cysts do not affect clinical response to controlled ovarian hyperstimulation for in vitro fertilization. Fertil Steril 1992;57:1017–1021

    PubMed  Google Scholar 

  21. Waegemaekers CT, van de Berg A, Helmerhorst FM, Naaktgeboren N: Ovarian cyst formation during the use of GnRH analogue in an IVF programme. Acta Eur Fertil 1987;18:411

    PubMed  Google Scholar 

  22. Herman A, Ron-El R, Golan A, Nahum A, Soffer Y, Caspi E: Follicle cysts after menstrual versus midluteal administration of gonadotropin-releasing hormone analog in in vitro fertilization. Fertil Steril 1990;53:854–858

    PubMed  Google Scholar 

  23. Ron-El R, Herman A, Golan A, van der Ven H, Caspi E, Diedrich K: The comparison of early follicular and midluteal administration of long-acting gonadotropin-releasing hormone. Fertil Steril 1990;54:233–237

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Calhaz-Jorge, C., Leal, F., Cordeiro, I. et al. Pituitary down-regulation in IVF cycles: Is it necessary to use strict criteria?. J Assist Reprod Genet 12, 615–619 (1995). https://doi.org/10.1007/BF02212585

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02212585

Key words

Navigation